A CASQ1 founder mutation in three Italian families with protein aggregate myopathy and hyperCKaemia

Claudia Di Blasi, Serena Sansanelli, Alessandra Ruggieri, Manuela Moriggi, Michele Vasso, Adamo Pio D'Adamo, Flavia Blasevich, Simona Zanotti, Cecilia Paolini, Feliciano Protasi, Frediano Tezzon, Cecilia Gelfi, Lucia Morandi, Mauro Pessia, Marina Mora

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background Protein aggregate myopathies are increasingly recognised conditions characterised by a surplus of endogenous proteins. The molecular and mutational background for many protein aggregate myopathies has been clarified with the discovery of several underlying mutations. Familial idiopathic hyperCKaemia is a benign genetically heterogeneous condition with autosomal dominant features in a high proportion of cases. Methods In 10 patients from three Italian families with autosomal dominant benign vacuolar myopathy and hyperCKaemia, we performed linkage analysis and exome sequencing as well as morphological and biochemical investigations. Results and conclusions We show, by Sanger and exome sequencing, that the protein aggregate myopathy with benign evolution and muscle inclusions composed of excess CASQ1, affecting three Italian families, is due to the D244G heterozygous missense mutation in the CASQ1 gene. Investigation of microsatellite markers revealed a common haplotype in the three families indicating consanguinity and a founder effect. Results from immunocytochemistry, electron microscopy, biochemistry and transfected cell line investigations contribute to our understanding of pathogenetic mechanisms underlining this defect. The mutation is common to other Italian patients and is likely to share a founder effect with them. HyperCKaemia in the CASQ1-related myopathy is common and sometimes the sole overt manifestation. It is likely that CASQ1 mutations may remain undiagnosed if a muscle biopsy is not performed, and the condition could be more common than supposed.

Original languageEnglish
Pages (from-to)617-626
Number of pages10
JournalJournal of Medical Genetics
Volume52
Issue number9
DOIs
Publication statusPublished - 2015

Fingerprint

Muscular Diseases
Founder Effect
Exome
Mutation
Consanguinity
Muscles
Missense Mutation
Biochemistry
Microsatellite Repeats
Haplotypes
Electron Microscopy
Immunohistochemistry
Biopsy
Cell Line
Protein Aggregates
Genes
Proteins

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

A CASQ1 founder mutation in three Italian families with protein aggregate myopathy and hyperCKaemia. / Di Blasi, Claudia; Sansanelli, Serena; Ruggieri, Alessandra; Moriggi, Manuela; Vasso, Michele; D'Adamo, Adamo Pio; Blasevich, Flavia; Zanotti, Simona; Paolini, Cecilia; Protasi, Feliciano; Tezzon, Frediano; Gelfi, Cecilia; Morandi, Lucia; Pessia, Mauro; Mora, Marina.

In: Journal of Medical Genetics, Vol. 52, No. 9, 2015, p. 617-626.

Research output: Contribution to journalArticle

Di Blasi, C, Sansanelli, S, Ruggieri, A, Moriggi, M, Vasso, M, D'Adamo, AP, Blasevich, F, Zanotti, S, Paolini, C, Protasi, F, Tezzon, F, Gelfi, C, Morandi, L, Pessia, M & Mora, M 2015, 'A CASQ1 founder mutation in three Italian families with protein aggregate myopathy and hyperCKaemia', Journal of Medical Genetics, vol. 52, no. 9, pp. 617-626. https://doi.org/10.1136/jmedgenet-2014-102882
Di Blasi, Claudia ; Sansanelli, Serena ; Ruggieri, Alessandra ; Moriggi, Manuela ; Vasso, Michele ; D'Adamo, Adamo Pio ; Blasevich, Flavia ; Zanotti, Simona ; Paolini, Cecilia ; Protasi, Feliciano ; Tezzon, Frediano ; Gelfi, Cecilia ; Morandi, Lucia ; Pessia, Mauro ; Mora, Marina. / A CASQ1 founder mutation in three Italian families with protein aggregate myopathy and hyperCKaemia. In: Journal of Medical Genetics. 2015 ; Vol. 52, No. 9. pp. 617-626.
@article{203a8c58009947abbc94246dc4d37598,
title = "A CASQ1 founder mutation in three Italian families with protein aggregate myopathy and hyperCKaemia",
abstract = "Background Protein aggregate myopathies are increasingly recognised conditions characterised by a surplus of endogenous proteins. The molecular and mutational background for many protein aggregate myopathies has been clarified with the discovery of several underlying mutations. Familial idiopathic hyperCKaemia is a benign genetically heterogeneous condition with autosomal dominant features in a high proportion of cases. Methods In 10 patients from three Italian families with autosomal dominant benign vacuolar myopathy and hyperCKaemia, we performed linkage analysis and exome sequencing as well as morphological and biochemical investigations. Results and conclusions We show, by Sanger and exome sequencing, that the protein aggregate myopathy with benign evolution and muscle inclusions composed of excess CASQ1, affecting three Italian families, is due to the D244G heterozygous missense mutation in the CASQ1 gene. Investigation of microsatellite markers revealed a common haplotype in the three families indicating consanguinity and a founder effect. Results from immunocytochemistry, electron microscopy, biochemistry and transfected cell line investigations contribute to our understanding of pathogenetic mechanisms underlining this defect. The mutation is common to other Italian patients and is likely to share a founder effect with them. HyperCKaemia in the CASQ1-related myopathy is common and sometimes the sole overt manifestation. It is likely that CASQ1 mutations may remain undiagnosed if a muscle biopsy is not performed, and the condition could be more common than supposed.",
author = "{Di Blasi}, Claudia and Serena Sansanelli and Alessandra Ruggieri and Manuela Moriggi and Michele Vasso and D'Adamo, {Adamo Pio} and Flavia Blasevich and Simona Zanotti and Cecilia Paolini and Feliciano Protasi and Frediano Tezzon and Cecilia Gelfi and Lucia Morandi and Mauro Pessia and Marina Mora",
year = "2015",
doi = "10.1136/jmedgenet-2014-102882",
language = "English",
volume = "52",
pages = "617--626",
journal = "Journal of Medical Genetics",
issn = "0022-2593",
publisher = "BMJ Publishing Group",
number = "9",

}

TY - JOUR

T1 - A CASQ1 founder mutation in three Italian families with protein aggregate myopathy and hyperCKaemia

AU - Di Blasi, Claudia

AU - Sansanelli, Serena

AU - Ruggieri, Alessandra

AU - Moriggi, Manuela

AU - Vasso, Michele

AU - D'Adamo, Adamo Pio

AU - Blasevich, Flavia

AU - Zanotti, Simona

AU - Paolini, Cecilia

AU - Protasi, Feliciano

AU - Tezzon, Frediano

AU - Gelfi, Cecilia

AU - Morandi, Lucia

AU - Pessia, Mauro

AU - Mora, Marina

PY - 2015

Y1 - 2015

N2 - Background Protein aggregate myopathies are increasingly recognised conditions characterised by a surplus of endogenous proteins. The molecular and mutational background for many protein aggregate myopathies has been clarified with the discovery of several underlying mutations. Familial idiopathic hyperCKaemia is a benign genetically heterogeneous condition with autosomal dominant features in a high proportion of cases. Methods In 10 patients from three Italian families with autosomal dominant benign vacuolar myopathy and hyperCKaemia, we performed linkage analysis and exome sequencing as well as morphological and biochemical investigations. Results and conclusions We show, by Sanger and exome sequencing, that the protein aggregate myopathy with benign evolution and muscle inclusions composed of excess CASQ1, affecting three Italian families, is due to the D244G heterozygous missense mutation in the CASQ1 gene. Investigation of microsatellite markers revealed a common haplotype in the three families indicating consanguinity and a founder effect. Results from immunocytochemistry, electron microscopy, biochemistry and transfected cell line investigations contribute to our understanding of pathogenetic mechanisms underlining this defect. The mutation is common to other Italian patients and is likely to share a founder effect with them. HyperCKaemia in the CASQ1-related myopathy is common and sometimes the sole overt manifestation. It is likely that CASQ1 mutations may remain undiagnosed if a muscle biopsy is not performed, and the condition could be more common than supposed.

AB - Background Protein aggregate myopathies are increasingly recognised conditions characterised by a surplus of endogenous proteins. The molecular and mutational background for many protein aggregate myopathies has been clarified with the discovery of several underlying mutations. Familial idiopathic hyperCKaemia is a benign genetically heterogeneous condition with autosomal dominant features in a high proportion of cases. Methods In 10 patients from three Italian families with autosomal dominant benign vacuolar myopathy and hyperCKaemia, we performed linkage analysis and exome sequencing as well as morphological and biochemical investigations. Results and conclusions We show, by Sanger and exome sequencing, that the protein aggregate myopathy with benign evolution and muscle inclusions composed of excess CASQ1, affecting three Italian families, is due to the D244G heterozygous missense mutation in the CASQ1 gene. Investigation of microsatellite markers revealed a common haplotype in the three families indicating consanguinity and a founder effect. Results from immunocytochemistry, electron microscopy, biochemistry and transfected cell line investigations contribute to our understanding of pathogenetic mechanisms underlining this defect. The mutation is common to other Italian patients and is likely to share a founder effect with them. HyperCKaemia in the CASQ1-related myopathy is common and sometimes the sole overt manifestation. It is likely that CASQ1 mutations may remain undiagnosed if a muscle biopsy is not performed, and the condition could be more common than supposed.

UR - http://www.scopus.com/inward/record.url?scp=84945371037&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84945371037&partnerID=8YFLogxK

U2 - 10.1136/jmedgenet-2014-102882

DO - 10.1136/jmedgenet-2014-102882

M3 - Article

C2 - 26136523

AN - SCOPUS:84945371037

VL - 52

SP - 617

EP - 626

JO - Journal of Medical Genetics

JF - Journal of Medical Genetics

SN - 0022-2593

IS - 9

ER -